Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Oger

Showing results (81-90 of 181) with videos related to

Pageof 19
Sort By:
Therapie|November 6, 2018
French administrative health care database (SNDS): The value of its enrichmentLucie-Marie Scailteux, Catherine Droitcourt, Frédéric Balusson, et al.
Therapie|December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 3, 2020
Among CMV-positive renal transplant patients receiving non-T-cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patientsHugoline Boulay, Emmanuel Oger, Diego Cantarovich, et al.
Thrombosis and Haemostasis|May 6, 2006
Recurrent venous thromboembolism under anticoagulant therapy: a high risk in adenocarcinoma?Renaud Descourt, Grégoire Le Gal, Francis Couturaud, et al.
Thrombosis and Haemostasis|October 4, 2002
Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?Emmanuel Oger, Karine Lacut, Grégoire Le Gal, et al.
Journal of Cardiac Failure|April 30, 2019
Do Patients With Acute Heart Failure and Preserved Ejection Fraction Have Heart Failure at Follow-Up: Implications of the Framingham CriteriaCamilla Hage, Ulrika LÖfstrÖm, Erwan Donal, et al.
International Journal of Cardiology|July 19, 2022
Functional tricuspid regurgitation: A clustering analysis and prognostic validation of three echocardiographic phenotypes in an external cohortMathilde Vely, Guillaume L'official, Elena Galli, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2012
Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell linesBénédicte Martin, Julien Edeline, Jean-Jacques Patard, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2017
Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance dataLucie-Marie Scailteux, Sébastien Vincendeau, Frédéric Balusson, et al.
The British Journal of Dermatology|February 10, 2023
The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanomaFlorence Poizeau, Frédéric Balusson, Florian Lemaitre, et al.
Pageof 19

Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Therapie|November 6, 2018
French administrative health care database (SNDS): The value of its enrichmentLucie-Marie Scailteux, Catherine Droitcourt, Frédéric Balusson, et al.
Therapie|December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 3, 2020
Among CMV-positive renal transplant patients receiving non-T-cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patientsHugoline Boulay, Emmanuel Oger, Diego Cantarovich, et al.
Thrombosis and Haemostasis|May 6, 2006
Recurrent venous thromboembolism under anticoagulant therapy: a high risk in adenocarcinoma?Renaud Descourt, Grégoire Le Gal, Francis Couturaud, et al.
Thrombosis and Haemostasis|October 4, 2002
Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?Emmanuel Oger, Karine Lacut, Grégoire Le Gal, et al.
Journal of Cardiac Failure|April 30, 2019
Do Patients With Acute Heart Failure and Preserved Ejection Fraction Have Heart Failure at Follow-Up: Implications of the Framingham CriteriaCamilla Hage, Ulrika LÖfstrÖm, Erwan Donal, et al.
International Journal of Cardiology|July 19, 2022
Functional tricuspid regurgitation: A clustering analysis and prognostic validation of three echocardiographic phenotypes in an external cohortMathilde Vely, Guillaume L'official, Elena Galli, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2012
Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell linesBénédicte Martin, Julien Edeline, Jean-Jacques Patard, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2017
Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance dataLucie-Marie Scailteux, Sébastien Vincendeau, Frédéric Balusson, et al.
The British Journal of Dermatology|February 10, 2023
The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanomaFlorence Poizeau, Frédéric Balusson, Florian Lemaitre, et al.
Pageof 19